<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00449423</url>
  </required_header>
  <id_info>
    <org_study_id>20060810</org_study_id>
    <nct_id>NCT00449423</nct_id>
  </id_info>
  <brief_title>Metabolic Modulation as Treatment in Acute Heart Failure</brief_title>
  <acronym>MEMO</acronym>
  <official_title>Metabolic Modulation as Treatment in Acute Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to evaluate whether metabolic modulation improves
      hemodynamics and outcome in acute heart failure
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute heart failure is a serious disease that despite modern therapies carries a high
      mortality. Inotropic drugs improve patient status but yield a higher risk of death. Previous
      studies have shown that myocardial contractility improves when glucose fermentation is up
      regulated and decreases when Free Fatty Acids are high. In a placebo-controlled design we
      wish to shift myocardial substrate metabolism towards increased glucose uptake and
      utilization and measure hemodynamics and biochemical markers of metabolism and prognosis.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    due to slow recruitment
  </why_stopped>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">October 2007</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac index</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>pulmonary Wedge Pressure</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Ejection fraction</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>myocardial glucose- and Free Fatty Acid-extraction</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cardiac output</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Regional left ventricle function</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>outcome day 6 and 30</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Acute Heart Failure</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>acipimox</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute heart failure

          -  NYHA class III - IV.

          -  ejection fraction &lt;35

        Exclusion Criteria:

          -  Age &lt;18 år or &gt;85 år,

          -  allergy

          -  renal failure

          -  recently developed brady- or tachy-arrythmias

          -  Serious infection

          -  Heart failure due to restrictive or hypertrophic cardiomyopathy or stenotic valvular
             heart disease

          -  Recent Myocardial infarction (&lt;6 Weeks)

          -  Pulmonary Wedge pressure &gt;30 mm Hg

          -  diabetes mellitus treated with insulin

          -  peptic ulcer

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mads Halbirk, dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aarhus University Hospital, Department of Cardiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aarhus University Hospital, Skejby Sygehus, Department of Cardiology</name>
      <address>
        <city>Aarhus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 19, 2007</study_first_submitted>
  <study_first_submitted_qc>March 19, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 20, 2007</study_first_posted>
  <last_update_submitted>October 24, 2007</last_update_submitted>
  <last_update_submitted_qc>October 24, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 25, 2007</last_update_posted>
  <keyword>Acute heart failure</keyword>
  <keyword>Metabolic modulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acipimox</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

